Dr. Meredith Christine McCormack, MD

Dr. McCormack practices at Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland.

Dr. McCormack's NPI, 1003887803, was assigned on January 30, 2006. Dr. McCormack graduated from Jefferson Medical College of Thomas Jefferson University in 1999. Dr. McCormack holds Maryland license D62621.

Dr. McCormack's primary practice is Johns Hopkins Hospital Nelson/Harvey Building, at 600 N Wolfe St, Baltimore, MD 21287 in Baltimore City. The practice phone is (855) 662-3017.

Dr. McCormack's primary practice is Johns Hopkins Hospital Nelson/Harvey Building in Baltimore, Maryland. Dr. McCormack is also affiliated with The Johns Hopkins Hospital. The medical group on file is Johns Hopkins University. Dmand AI also links Dr. McCormack to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. McCormack practices, 2 sites in all. Vendor and product names are available with a free account.

Pulmonary disease is Dr. McCormack's primary specialty in the NPI Registry, under taxonomy code 207RP1001X. Dr. McCormack is licensed in Maryland.

CMS data shows 1,246 Medicare services from Dr. McCormack across 12 procedure codes in 2024, for 571 Medicare patients. Medicare paid $39,082 for them.

CMS counts 571 Medicare patients who saw Dr. McCormack in 2024. The largest group is 65 to 74, with 277 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 2.43, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. McCormack's median patient age at 71, with 60% women.

In 2024, Dr. McCormack wrote 351 Medicare Part D claims for 55 patients. 46% of them were for generic drugs. CMS names the drug for 239 of them, across 13 drugs with 11 or more claims each, at $126,433 in total drug cost. In 2023, CMS named 165 claims across 8 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 83 out of 100 for Dr. McCormack for performance year 2024, reported as part of a group. CMS lists Dr. McCormack as offering telehealth.

Dmand AI links 200 papers to Dr. McCormack, published from 2010 to 2025. 2021 was the busiest year, with 17. The most frequent topics are Asthma, Pulmonary Disease, Chronic Obstructive and Lung. Dr. McCormack has published most often in Am J Respir Crit Care Med. Dr. McCormack's most frequent co-authors are Elizabeth Cotton Matsui, MD, Gregory Bruce Diette, MD and Robert Wise, MD.

Dmand AI links Dr. McCormack to 1 clinical trial. Conditions studied include Dyspnea and Hypoxia.

CMS Open Payments shows 23 general payments to Dr. McCormack from 5 drug and device companies from 2019 to 2025. Consulting fees make up the largest share, 87% of the total. GlaxoSmithKline, LLC. paid the most, $28,759.

Dr. McCormack graduated from Jefferson Medical College of Thomas Jefferson University in 1999.